[Federal Register Volume 67, Number 202 (Friday, October 18, 2002)]
[Notices]
[Pages 64384-64385]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-26538]



[[Page 64384]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Program Announcement 02212]


Support for Civil Society Organizations Responding to HIV/AIDS in 
Mali; Notice of Award of Funds

A. Purpose

    The Centers for Disease Control and Prevention (CDC) announces the 
availability of fiscal year (FY) 2002 funds for a Cooperative Agreement 
program to Support Civil Society Organizations Responding to HIV/AIDS 
in high risk groups in Mali.
    The purpose of this cooperative agreement is to provide support to 
civil society organizations responding to the HIV/AIDS epidemic in 
Mali. Specifically, CDC intends to focus its support on (1) Non-
governmental organizations (NGOs) with national or regional missions 
and activities or cross-cutting activities that focus on HIV/AIDS 
prevention in high risk groups and are under the auspices of the Groupe 
Pivot umbrella NGO organization; (2) NGO infrastructure or 
administrative support that is needed to complement already existing 
administrative and program management capacities, including assistance 
with program planning, accountability and monitoring and evaluation; 
and (3) providing support of NGO implementation of Sexually Transmitted 
Infection (STI) referral or direct treatment services based on the 
National STI syndromic treatment algorithms and utilizing outreach, 
education, counseling and partner referral mechanisms. See Attachment I 
for additional background information.
    Measurable outcomes of the program will be in alignment with the 
following performance goal for the National Center for HIV, STD and TB 
Prevention, Global AIDS Program: Working with other countries, USAID, 
international, and U.S. government agencies, reduce the number of new 
HIV infections among 15 to 24 year olds in sub-Saharan Africa from an 
estimated 2 million by 2005.

B. Eligible Applicants

    Assistance will be provided only to the Groupe Pivot organization 
based in Bamako, Mali. No other applications are solicited.
    This announcement is restricted to Groupe Pivot because it is the 
only organization in Mali that serves as an umbrella organization for 
hundreds of non-governmental organizations located through the country. 
Groupe Pivot is the only organization in Mali that provides training, 
technical assistance and financial support to non-governmental 
organizations/community-based organizations (NGOs/CBOs) for the 
planning, implementation and management of health and population 
projects. CDC's support to NGOs/CBOs for STI/HIV prevention at the 
community level will be greatly enhanced by collaboration with Groupe 
Pivot.

C. Availability of Funds

    Approximately $100,000 is available in FY 2002 for Groupe Pivot to 
fund multiple awards to NGOs averaging from $6,500 to $19,500 per 
award. It is expected that the umbrella award will begin on or about 
September 1, 2002, and will be made for a 12-month budget period within 
a project period of up to three (3) years. Funding estimates may change 
and will be dependent on extension of CDC agreement with USAID in Mali.
    Continuation awards within an approved project period will be made 
on the basis of satisfactory progress as evidenced by required reports 
and the availability of funds. Matching funds are not required for this 
program.
    Funds are available under this announcement to support specific 
HIV/AIDS prevention activities. These activities are:
    [sbull] Development of STI referral services for high risk groups 
and their partners.
    [sbull] Development of on-site STI services for high risk groups 
and their partners, when appropriate.
    [sbull] STI/HIV outreach services and STI/HIV education programs 
for high risk groups and partners.
    [sbull] Monitoring and evaluation of program indicators, such as 
number of persons referred and treated, number of condoms distributed 
and number of education sessions held by the sub-grantee.
    [sbull] Development of condom promotion and distribution programs 
among high risk groups, including condom skills training.

Use of Funds

STI/HIV Prevention
    Funds may be utilized by grantee or sub-grantees only in activities 
associated with HIV/AIDS and STI prevention in particular. They are 
also targeted to high risk groups.
Antiretroviral Drugs
    The purchase of antiretrovirals, reagents, and laboratory equipment 
for antiretroviral treatment projects requires pre-approval from the 
Division of STD Prevention--International Activities.
Contracts
    Applicant may contract or sign memoranda of understanding with 
other organizations under these cooperative agreements (i.e. local 
NGOs), however, applicant must perform a substantial portion of the 
activities, including program management and operations and ultimate 
responsibility for delivery of prevention services for which funds are 
requested.
    The costs that are generally allowable in grants to domestic 
organizations are likewise allowable to foreign institutions and 
international organizations, with the following exceptions:

    Indirect Costs: With the exception of the American University, 
Beirut, the Gorgas Memorial Institute, and the World Health 
Organization, indirect costs will not be paid (either directly or 
through a sub-award) to organizations located outside the 
territorial limits of the United States or to international 
organizations regardless of their location.

    All requests for funds, including the budget contained in the 
application, shall be stated in U.S. dollars. All proposals must be 
written in English. Once an award is made, the Department of Health and 
Human Services (DHHS) will not compensate foreign grantees for currency 
exchange fluctuations through the issuance of supplemental awards.
Needle Exchange
    No funds appropriated under this Act shall be used to carry out any 
program of distributing sterile needles or syringes for the hypodermic 
injection of any illegal drug.

D. Where To Obtain Additional Information

    CDC announcement information can be found on the CDC home page 
Internet address--http://www.cdc.gov. Click on ``Funding'' then 
``Grants and Cooperative Agreements.''
    For business management technical assistance, contact: Cynthia 
Collins, Grants Management Specialist, Grants Management Branch, 
Procurement & Grants Office, Centers for Disease Control and 
Prevention, Room 3000, 2920 Brandywine Road, Atlanta, GA 30341-4146, 
Telephone: (770) 488-2757, e-mail address: [email protected].
    For program technical assistance, contact: Famory Fofana, MD, 
Centers for Disease Control, Bamako-Coura Rue 371, Porte 397, PNLS, 
Cour PMI Centrale (SSS Commune III), BAMAKO--Republique du Mali, e-mail 
address: [email protected].


[[Page 64385]]


    Dated: October 9, 2002.
Edward J. Schultz,
Deputy Director, Procurement and Grants Office, Centers for Disease 
Control and Prevention.
[FR Doc. 02-26538 Filed 10-17-02; 8:45 am]
BILLING CODE 4163-18-P